Heat Biologics Announces Its Phase 1/2 Study of HS-410 in Bladder Cancer Is Open for Enrollment Dec 30, 2013
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development Dec 17, 2013
Heat Biologics Successfully Completes Manufacturing of HS-410 to Start Phase 1/2 Bladder Cancer Trial Nov 25, 2013
Heat Biologics, Inc. Reports Third Quarter 2013 Financial Results and Provides Clinical Programs Review Nov 14, 2013
